One of the most significant applications of nanomedicine in cancer is targeted drug delivery. This approach aims to deliver chemotherapeutic agents directly to cancer cells while minimizing damage to healthy tissues. Nanoparticles can be engineered to recognize and bind to specific markers on cancer cells, ensuring that the drug is released precisely where it is needed. This reduces side effects and increases the efficacy of the treatment.
